Conferences

Biotechgate Digital Partnering is a virtual conference designed to support the business development of Biotech, Medtech and Pharma companies. Join five days of digital partnering and establish new global connections thanks to pre-arranged one-on-one Zoom meetings, along with informal networking events and workshops.

Delegates from Venture Valuation and Biotechgate will attend the event.

We are pleased to announce that the 18th Annual European Life Sciences CEO Forum (#Sachs_ELSF) will take place on the 26th - 27th of February 2025 at the Hilton Zurich Airport Hotel. While the European HealthTech CEO Forum will not be held in 2025, the ELSF programme will include some HealthTech topics, such as AI, convergence, and diagnostics. You will also have the opportunity to register for the HealthTech Investment Forum during the Sachs Autumn Life Sciences Week later in the year. The success and longevity of the forum is built on the goodwill and repeat attendance of major corporate and financial investors, and pharma licensing executives and advisors, who are seeking to network with biotechs. The programme and presentations allow all to keep up with the latest industry developments and strategize for 2025. The physical programme will consist of the usual panels and keynotes, which will be available on demand from the 4th of March. Additionally, there will be pre-arranged in-person meetings, live and on-demand company showcases, and a reception. During the online week, virtual meetings will be available through the audio/video online meeting system. The main programme for the 18th Annual ELSF is spread over 2 days (26th - 27th of February) and will feature more than 12 hours of high-level keynotes and panel discussions. In addition, there will be a global company showcase of 50+ presentations by established public, private, emerging, and seed companies, offering innovative solutions and seeking investment and partnering opportunities. This will include a limited number of live presentations taking place in dedicated presentation tracks, alongside virtual company showcases, which will be available on demand during the virtual week. We anticipate 400+ delegates will register for the forum from all Life Sciences sectors, with the target audience being corporate and financial investors/partners, banks, and advisors with part of the audience participating virtually. The In-Person meetings will take place on the 26th - 27th of February, while virtual meetings will occur on the 4th - 6th of March. For the virtual meetings, the system will allow you to have a secure audio/video call, as well as the option to present slides using a screen share function and we will have a dedicated room for in-person meetings. We expect around 2000 meetings to be completed during the event.

Delegates from Venture Valuation and Biotechgate will attend the event.

Join us in Miami on March 10-11, 2025, for Investival Showcase USA, North America's premier biotech, medtech, and digital health networking event. This cutting-edge platform connects innovators with investors and partners through exclusive 1:1 sessions. Building on a decade of European success, we're bringing this dynamic format stateside. Whether you're a start-up or seasoned investor, don't miss this opportunity to shape the future of healthcare innovation in vibrant Miami.

Delegates from Venture Valuation and Biotechgate will attend the event.

Swiss Nordic Bio in Zurich is a high-level partnering and investor event where Swiss and Nordic biotech and healthtech startups, pharmaceutical companies and investors meet. Swiss Nordic Bio carries 18 years of tradition, previously Swiss Scandinavian Bio-Business Seminar, and is organised by the Nordic countries in cooperation with Swiss partners. The conference has a broad focus within biotech, healthtech and pharma (drug development, drug delivery, bio materials, medical device, diagnostics, contract manufacturing, CRO, etc.) and gathers small, early stage companies as well as global, commercial

Delegates from Venture Valuation and Biotechgate will attend the event.

The eighteenth annual BIO-Europe Spring® conference is back in-person and will be taking place from 17 to 19 March 2025 in Milan, Italy. Building and nurturing relationships is an essential part of the progression of successful business partnerships. BIO-Europe Spring 2025 will offer a fusion of innovative digital solutions and a vibrant on-site event of unprecedented scope. Expanding on the success of EBD Group’s flagship conference, BIO-Europe®, BIO-Europe Spring will bring together over 3,700 leading executives from around the world. Specifically, we will host more than 20,000 partnering meetings to connect leaders from academia, start-up, and scale-up biotech companies with forward-thinking investors and pharma companies. Along with world-class workshops and panels, innovative company presentations, active exhibition and a variety of networking opportunities make this event an unrivalled forum for companies across the biotech value chain to meet and do business.

Delegates from Venture Valuation and Biotechgate will attend the event.

The RESI Europe Conference 2025 is coming back to Barcelona! Hosted by Life Science Nation (LSN) in collaboration with Biocat, RESI Europe continues its mission to connect healthcare innovators with global investors and partners. This year’s event features an in-person conference on April 1, 2025, at The InterContinental Barcelona, followed by two days of virtual partnering on April 2-3, 2025. Part of the globally recognized Redefining Every Stage Investments (RESI) series, this conference offers unparalleled opportunities for life science companies in drugs, devices, diagnostics, and digital health. With 250+ global investors/in-licensors and 250+ life science innovators expected, RESI Europe is your gateway to securing capital, partnerships, and licensing deals.

Delegates from Venture Valuation and Biotechgate will attend the event.

ioTrinity, now in its 19th year, is OBN's flagship two-day conference for the life sciences industry, designed to catalyse growth for all who attend. The two-day conference programme for 2025 features a dual track of showcase presentations from R&D companies at around the Series A stage, across 14 different therapy areas, a packed business & investment track, sponsors exhibition, networking events, private partnering meetings and an academic poster presentation. After another sell-out year in 2024, we expect an expanded and refreshed audience of c900 delegates to attend BioTrinity 2025, comprising a mix of early stage and emerging life sciences R&D companies, investors, big pharma, academics, charities, government, and a broad range of valued service providers. Delegates attend from the UK, Europe the U.S, Japan, China, Australia and beyond, and the team welcome discussion with clusters to discuss their delegation requirements.

Delegates from Venture Valuation and Biotechgate will attend the event.

An Introductory Course: Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.

Delegates from Venture Valuation and Biotechgate will attend the event.

The LSX World Congress is Europe's leading partnering, strategy, and investment event, with qualified 1:1 partnering at its core. We gather senior life science industry decision-makers from the world's most innovative biopharma, medtech and healthtech companies with investors, senior BD&L teams, R&D leaders and industry KOLs. Together, they share best practices, forge partnerships, and discuss investment – to revolutionise healthcare.

Delegates from Venture Valuation and Biotechgate will attend the event.

The Swiss Biotech Day is a premier biotechnology conference in Europe, attracting professionals from the global life sciences community. In 2024, it will once again provide a platform for networking, engaging discussions, and the exploration of advancements in R&D, manufacturing, data management, artificial intelligence, and innovative financing. International biotech delegations use the “Global Village” to strengthen their ties with Switzerland as a biotech hub and promote cross-border investments, public-private partnerships, research and development collaborations and exchange of talent.

Delegates from Venture Valuation and Biotechgate will attend the event.

The LSX Nordic Congress connects life science and healthcare industry leaders with international investment and strategic partners to further the growth, development and internationalisation of Nordic life science and healthcare innovation. The mission is to facilitate ever greater international investment into the region, as well as foster strategic partnerships and collaboration with key international healthcare stakeholders.

Delegates from Venture Valuation and Biotechgate will attend the event.

The LSX World Congress USA gathers leaders from the US biotech, medtech, and healthtech sectors to network, showcase innovations, and explore partnership opportunities. It offers a unique platform for CEOs, investors, and pharma executives to engage in meaningful discussions and collaborative sessions, shaping the future of healthcare technology.

Delegates from Venture Valuation and Biotechgate will attend the event.

Investival Showcase is your Ultimate Biotech, Healthtech and Medtech Networking & Pitching Event in London. With 8 incredible presenting stages for startup, growth stage and publicly listed Biotech, Healthtech, Medtech, TechBio, Digital Health and Deeptech companies.

Delegates from Venture Valuation and Biotechgate will attend the event.